NCT01093911 - Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Immune System DiseasesAutoimmune DiseasesLupus Erythematosus, SystemicSkin and Connective Tissue DiseasesConnective Tissue Disease

Interventions

BIOLOGICAL

CDP7657

Ascending single doses of CDP7657

OTHER

Placebo

Placebo: 0.9% sodium chloride aqueous solution

Trial Locations (8)

6, Leuven

9, Sofia

1, Berlin

2, Erlangen

3, Frankfurt

4, Hanover

8, Kiel

7, Münster